An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma
- PMID: 14716802
- DOI: 10.1002/bjs.4366
An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma
Abstract
Background: The outcome after surgery for intrahepatic cholangiocarcinoma (ICC) is dismal and data on long-term survival are not available. This study evaluated prognostic indicators and characteristic features of long-term survivors after hepatic resection for ICC.
Methods: Thirty-one patients who had undergone hepatic resection for ICC were studied. Univariate and multivariate survival analyses of clinicopathological data included an intraductal papillary carcinoma component (IDPCC) in the tumour, which was defined as the histological demonstration of cancer cells growing in a papillary fashion into the lumen of the large bile duct.
Results: The overall cumulative survival rate after hepatic resection for ICC was 51.2 per cent at 1 year and 24.5 per cent at 5 years, with a mean(s.d.) survival time of 11(4) months. The presence of IDPCC (P = 0.003), curative resection (P = 0.009) and the absence of perineural invasion (P = 0.040) were identified as favourable independent prognostic factors in multivariate analysis. Eight patients with IDPCC had a 5-year survival rate of 87.5 per cent and a mean(s.d.) survival time of 69(13) months. All seven patients who survived for more than 5 years after surgery had IDPCC, regardless of the gross appearance of the tumour.
Conclusion: An IDPCC in the tumour resulted in long-term survival after hepatic resection for ICC.
Copyright 2003 British Journal of Surgery Society Ltd.
Similar articles
-
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.Br J Surg. 2002 Dec;89(12):1525-31. doi: 10.1046/j.1365-2168.2002.02268.x. Br J Surg. 2002. PMID: 12445060
-
Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6. Hepatogastroenterology. 2002. PMID: 11995440
-
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.Hepatogastroenterology. 2007 Mar;54(74):346-9. Hepatogastroenterology. 2007. PMID: 17523271
-
What constitutes long-term survival after surgery for hilar cholangiocarcinoma?Cancer. 1997 Jan 1;79(1):26-34. Cancer. 1997. PMID: 8988723 Review.
-
[Intrahepatic bile duct carcinoma (cholangiocarcinoma)].Nihon Geka Gakkai Zasshi. 1997 May;98(5):484-90. Nihon Geka Gakkai Zasshi. 1997. PMID: 9213313 Review. Japanese.
Cited by
-
A case of asymptomatic intraductal papillary neoplasm of the bile duct without hepatolithiasis.World J Gastroenterol. 2008 Mar 14;14(10):1625-9. doi: 10.3748/wjg.14.1625. World J Gastroenterol. 2008. PMID: 18330960 Free PMC article.
-
Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma.J Cancer Res Clin Oncol. 2006 Dec;132(12):805-10. doi: 10.1007/s00432-006-0129-1. Epub 2006 Jun 23. J Cancer Res Clin Oncol. 2006. PMID: 16794828 Free PMC article.
-
A huge intraductal papillary mucinous carcinoma of the bile duct treated by right trisectionectomy with caudate lobectomy.World J Surg Oncol. 2009 Dec 5;7:93. doi: 10.1186/1477-7819-7-93. World J Surg Oncol. 2009. PMID: 19961613 Free PMC article.
-
Intrahepatic cholangiocarcinoma: clinicopathological differences between peripheral type and hilar type.J Gastrointest Surg. 2012 Mar;16(3):540-8. doi: 10.1007/s11605-011-1730-4. Epub 2011 Oct 20. J Gastrointest Surg. 2012. PMID: 22012305
-
External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.Br J Radiol. 2017 Aug;90(1076):20170061. doi: 10.1259/bjr.20170061. Epub 2017 May 23. Br J Radiol. 2017. PMID: 28466653 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical